safingol has been researched along with Lymphopenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cane, LM; Carvajal, RD; Dickson, MA; Gonen, M; Merrill, AH; Schwartz, GK | 1 |
1 trial(s) available for safingol and Lymphopenia
Article | Year |
---|---|
A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Humans; Lymphopenia; Lysophospholipids; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Sphingosine; Treatment Outcome | 2011 |